| Literature DB >> 32032627 |
Louise Alessandra Mesentier-Louro1, Mohammed Ali Shariati1, Roopa Dalal1, Alexandra Camargo1, Varun Kumar1, Elya Ali Shamskhou2, Vinicio de Jesus Perez2, Yaping Joyce Liao3.
Abstract
Vision loss is a devastating consequence of systemic hypoxia, but the cellular mechanisms are unclear. We investigated the impact of acute hypoxia in the retina and optic nerve. We induced systemic hypoxia (10% O2) in 6-8w mice for 48 h and performed in vivo imaging using optical coherence tomography (OCT) at baseline and after 48 h to analyze structural changes in the retina and optic nerve. We analyzed glial cellular and molecular changes by histology and immunofluorescence and the impact of pretreatment with 4-phenylbutyric acid (4-PBA) in oligodendroglia survival. After 48 h hypoxia, we found no change in ganglion cell complex thickness and no loss of retinal ganglion cells. Despite this, there was significantly increased expression of CCAAT-enhancer-binding protein homologous protein (CHOP), a marker of endoplasmic reticulum stress, in the retina and optic nerve. In addition, hypoxia induced obvious increase of GFAP expression in the anterior optic nerve, where it co-localized with CHOP, and significant loss of Olig2+ oligodendrocytes. Pretreatment with 4-PBA, which has been shown to reduce endoplasmic reticulum stress, rescued total Olig2+ oligodendrocytes and increased the pool of mature (CC-1+) but not of immature (PDGFRa+) oligodendrocytes. Consistent with a selective vulnerability of the retina and optic nerve in hypoxia, the most striking changes in the 48 h murine model of hypoxia were in glial cells in the optic nerve, including increased CHOP expression in the astrocytes and loss of oligodendrocytes. Our data support a model where glial dysfunction is among the earliest events in systemic hypoxia - suggesting that glia may be a novel target in treatment of hypoxia.Entities:
Keywords: Astrocytes; CHOP; ER stress; Endoplasmic reticulum; Glia; Hypoxia; Oligodendrocytes; Optic neuropathy; Retinal ganglion cells
Mesh:
Year: 2020 PMID: 32032627 PMCID: PMC7673281 DOI: 10.1016/j.exer.2020.107957
Source DB: PubMed Journal: Exp Eye Res ISSN: 0014-4835 Impact factor: 3.467